- Home
- COYA vs ANEB Comparison
COYA vs ANEB Comparison
Compare COYA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- ANEB
- Stock Information
- Founded
- COYA 2020
- ANEB 2020
- Country
- COYA United States
- ANEB United States
- Employees
- COYA N/A
- ANEB N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- COYA Health Care
- ANEB Health Care
- Exchange
- COYA Nasdaq
- ANEB Nasdaq
- Market Cap
- COYA 107.0M
- ANEB 117.1M
- IPO Year
- COYA 2022
- ANEB 2021
- Fundamental
- Price
- COYA $6.15
- ANEB $2.50
- Analyst Decision
- COYA Strong Buy
- ANEB Buy
- Analyst Count
- COYA 4
- ANEB 2
- Target Price
- COYA $16.50
- ANEB $8.00
- AVG Volume (30 Days)
- COYA 59.2K
- ANEB 1.2M
- Earning Date
- COYA 08-12-2025
- ANEB 09-24-2025
- Dividend Yield
- COYA N/A
- ANEB N/A
- EPS Growth
- COYA N/A
- ANEB N/A
- EPS
- COYA N/A
- ANEB N/A
- Revenue
- COYA $423,452.00
- ANEB N/A
- Revenue This Year
- COYA $40.52
- ANEB N/A
- Revenue Next Year
- COYA N/A
- ANEB N/A
- P/E Ratio
- COYA N/A
- ANEB N/A
- Revenue Growth
- COYA N/A
- ANEB N/A
- 52 Week Low
- COYA $4.65
- ANEB $0.80
- 52 Week High
- COYA $10.24
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- COYA 51.12
- ANEB 55.36
- Support Level
- COYA $5.60
- ANEB $2.22
- Resistance Level
- COYA $6.28
- ANEB $2.66
- Average True Range (ATR)
- COYA 0.41
- ANEB 0.20
- MACD
- COYA -0.04
- ANEB -0.08
- Stochastic Oscillator
- COYA 49.11
- ANEB 28.78
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.